Standard BioTools Inc

NASDAQ:LAB  
1.51
+0.08 (+5.59%)
4:50:01 PM EDT: $1.45 -0.06 (-3.97%)
Earnings Announcements

Standard Biotools Announces Third Quarter 2022 Financial Results

Published: 11/08/2022 23:06 GMT
Standard BioTools Inc (LAB) - Standard Biotools Announces Third Quarter 2022 Financial Results.
Standard Biotools Inc - Q3 Core Product and Services Revenue Increase of 30% Sequentially to $24.8 Million.
Standard Biotools Inc - on Track to Achieve Positive Free Cash Flow by Year-end 2024.
Standard Biotools Inc - Cash, Cash Equivalents, and Short-term Investments As of September 30, 2022, Were $185.2 Million.
Standard Biotools Inc - Qtrly Loss per Share $0.37.